To determine the endemicity of hepatitis B, what should be measured ?
## Core Concept
The endemicity of hepatitis B in a population is determined by measuring the prevalence of specific markers that indicate current or past infection. Hepatitis B virus (HBV) infection can be assessed through various serological markers, each providing information on the stage of infection or immunity.
## Why the Correct Answer is Right
The correct answer, **Hepatitis B surface antigen (HBsAg)**, is a marker of current HBV infection. HBsAg is the earliest indicator of acute HBV infection and also appears in chronic HBV infection. Its presence indicates that the person is infectious. Measuring HBsAg prevalence in a population is a direct way to assess the endemicity of hepatitis B because it identifies individuals who are currently infected and potentially contagious.
## Why Each Wrong Option is Incorrect
- **Option A:** Anti-HBc (antibody to hepatitis B core antigen) alone does not indicate the endemicity as it appears in both acute and chronic infections and can persist for life. It signifies exposure but does not differentiate between current and past infections.
- **Option B:** Anti-HBs (antibody to hepatitis B surface antigen) indicates immunity, either from vaccination or past infection. While important, it does not directly reflect the current endemicity of infectious individuals.
- **Option C:** HBeAg (hepatitis B e-antigen) is a marker of viral replication and infectivity but is not used to determine endemicity in a population as it is not as universally present as HBsAg in infected individuals.
## Clinical Pearl / High-Yield Fact
A key point to remember is that **HBsAg prevalence is categorized into three levels of endemicity**:
- **Low endemicity** (7% HBsAg positive).
Understanding these levels helps in planning public health interventions.
## Correct Answer Line
**Correct Answer: C. Hepatitis B surface antigen (HBsAg).**